AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. THC
  4. [Form 4] Tenet Healthcare Corporation New Insider Trading Activity

[Form 4] Tenet Healthcare Corporation New Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Saumya Sutaria, CEO and director of Tenet Healthcare Corporation (THC), received a grant of 106,682 shares of common stock that vested as performance-based restricted stock on 08/13/2025. The filing states the award was earned after the Human Resources Committee certified achievement of performance targets for the period January 1, 2021 to June 30, 2025. Following the transaction, Sutaria beneficially owns 475,365 shares. The Form 4 was signed by an attorney-in-fact on 08/15/2025.

Saumya Sutaria, amministratore delegato e membro del consiglio di Tenet Healthcare Corporation (THC), ha ricevuto una concessione di 106.682 azioni ordinarie che sono diventate vincolate in base alle prestazioni il 13/08/2025. Il documento indica che l'assegnazione 猫 stata maturata dopo che il Comitato Risorse Umane ha certificato il raggiungimento degli obiettivi di performance per il periodo 1 gennaio 2021 - 30 giugno 2025. Dopo la transazione, Sutaria detiene beneficiariamente 475.365 azioni. Il Modulo 4 猫 stato firmato da un procuratore il 15/08/2025.

Saumya Sutaria, consejera delegada y directora de Tenet Healthcare Corporation (THC), recibi贸 una concesi贸n de 106.682 acciones ordinarias que se hicieron efectivas como acciones restringidas basadas en rendimiento el 13/08/2025. El informe indica que la adjudicaci贸n se obtuvo tras la certificaci贸n del Comit茅 de Recursos Humanos sobre el cumplimiento de los objetivos de rendimiento para el periodo 1 de enero de 2021 al 30 de junio de 2025. Tras la operaci贸n, Sutaria posee beneficiariamente 475.365 acciones. El Formulario 4 fue firmado por un apoderado el 15/08/2025.

Saumya Sutaria, 韰岆劮 項姢旒�鞏� 旖旐嵓霠堨澊靺�(THC) 斓滉碃瓴届榿鞛� 瓴� 鞚挫偓,電� 106,682欤检潣 氤错喌欤茧ゼ 攵�鞐皼鞎橃溂氅� 鞚措姅 2025-08-13鞐� 靹标臣 旮半皹 鞝滍暅欤茧 頇曥爼霅橃棃鞀惦媹雼�. 鞝滌稖靹滊鞐� 霐半ゴ氅� 鞚� 靾橃棳電� 鞚胳偓鞙勳洂須岅皜 2021雲� 1鞗� 1鞚紐2025雲� 6鞗� 30鞚� 旮瓣皠鞚� 靹标臣 氇╉憸 雼劚鞚� 鞚胳頃� 頉勳棎 鞚措（鞏挫雼り碃 頃╇媹雼�. 瓯半灅 頉� Sutaria電� 齑� 475,365欤茧ゼ 鞁れ鞝侅溂搿� 氤挫湢頃橁矊 霅橃棃鞀惦媹雼�. Form 4電� 2025-08-15鞐� 鞙勳瀯鞚�(attorney-in-fact)鞐� 鞚橅暣 靹滊獏霅橃棃鞀惦媹雼�.

Saumya Sutaria, PDG et administratrice de Tenet Healthcare Corporation (THC), a re莽u une attribution de 106 682 actions ordinaires qui ont 茅t茅 acquises sous forme d'actions restreintes li茅es 脿 la performance le 13/08/2025. Le dossier pr茅cise que l'attribution a 茅t茅 obtenue apr猫s que le comit茅 des ressources humaines ait certifi茅 la r茅alisation des objectifs de performance pour la p茅riode 1er janvier 2021 au 30 juin 2025. 脌 la suite de la transaction, Sutaria d茅tient 脿 titre b茅n茅ficiaire 475 365 actions. Le formulaire 4 a 茅t茅 sign茅 par un mandataire le 15/08/2025.

Saumya Sutaria, CEO und Direktorin von Tenet Healthcare Corporation (THC), erhielt eine Zuteilung von 106.682 Stammaktien, die am 13.08.2025 als leistungsgebundene Restricted Stock f盲llig wurden. Die Meldung gibt an, dass die Auszeichnung nach der Zertifizierung der Erreichung der Leistungsziele durch das Personal颅komitee f眉r den Zeitraum 1. Januar 2021 bis 30. Juni 2025 verdient wurde. Nach der Transaktion verf眉gt Sutaria wirtschaftlich 眉ber 475.365 Aktien. Das Formular 4 wurde am 15.08.2025 von einem Bevollm盲chtigten unterzeichnet.

Positive
  • Performance-based award vested, indicating achievement of committee-certified targets for the period Jan 1, 2021 to Jun 30, 2025
  • Insider ownership increased by 106,682 shares to a total of 475,365 shares, strengthening executive alignment with shareholders
Negative
  • None.

Insights

TL;DR: CEO received a performance-based equity award that vested after multi-year goals; holding stake increased materially.

The filing documents a vested grant of 106,682 shares earned by the CEO for performance covering a multi-year period ending June 30, 2025. This reflects alignment of executive compensation with long-term objectives and increases insider ownership to 475,365 shares. Because the award is described as performance-based and certified by the Human Resources Committee, the transaction is a routine governance outcome rather than a discretionary one-off. No derivative instruments or dispositions were reported.

TL;DR: Substantial performance-based restricted stock vested, boosting executive equity without cash exercise price.

The record shows a grant settled in common stock with a reported price of $0, consistent with restricted stock awards that vest contingent on performance. The award was tied to a long performance period (January 1, 2021 to June 30, 2025), indicating multi-year incentive alignment. The increase of 106,682 shares meaningfully raises the reported beneficial ownership level to 475,365 shares, which can affect dilution metrics and total executive stake calculations in compensation analyses. The Form 4 reports no sales or derivative transactions.

Saumya Sutaria, amministratore delegato e membro del consiglio di Tenet Healthcare Corporation (THC), ha ricevuto una concessione di 106.682 azioni ordinarie che sono diventate vincolate in base alle prestazioni il 13/08/2025. Il documento indica che l'assegnazione 猫 stata maturata dopo che il Comitato Risorse Umane ha certificato il raggiungimento degli obiettivi di performance per il periodo 1 gennaio 2021 - 30 giugno 2025. Dopo la transazione, Sutaria detiene beneficiariamente 475.365 azioni. Il Modulo 4 猫 stato firmato da un procuratore il 15/08/2025.

Saumya Sutaria, consejera delegada y directora de Tenet Healthcare Corporation (THC), recibi贸 una concesi贸n de 106.682 acciones ordinarias que se hicieron efectivas como acciones restringidas basadas en rendimiento el 13/08/2025. El informe indica que la adjudicaci贸n se obtuvo tras la certificaci贸n del Comit茅 de Recursos Humanos sobre el cumplimiento de los objetivos de rendimiento para el periodo 1 de enero de 2021 al 30 de junio de 2025. Tras la operaci贸n, Sutaria posee beneficiariamente 475.365 acciones. El Formulario 4 fue firmado por un apoderado el 15/08/2025.

Saumya Sutaria, 韰岆劮 項姢旒�鞏� 旖旐嵓霠堨澊靺�(THC) 斓滉碃瓴届榿鞛� 瓴� 鞚挫偓,電� 106,682欤检潣 氤错喌欤茧ゼ 攵�鞐皼鞎橃溂氅� 鞚措姅 2025-08-13鞐� 靹标臣 旮半皹 鞝滍暅欤茧 頇曥爼霅橃棃鞀惦媹雼�. 鞝滌稖靹滊鞐� 霐半ゴ氅� 鞚� 靾橃棳電� 鞚胳偓鞙勳洂須岅皜 2021雲� 1鞗� 1鞚紐2025雲� 6鞗� 30鞚� 旮瓣皠鞚� 靹标臣 氇╉憸 雼劚鞚� 鞚胳頃� 頉勳棎 鞚措（鞏挫雼り碃 頃╇媹雼�. 瓯半灅 頉� Sutaria電� 齑� 475,365欤茧ゼ 鞁れ鞝侅溂搿� 氤挫湢頃橁矊 霅橃棃鞀惦媹雼�. Form 4電� 2025-08-15鞐� 鞙勳瀯鞚�(attorney-in-fact)鞐� 鞚橅暣 靹滊獏霅橃棃鞀惦媹雼�.

Saumya Sutaria, PDG et administratrice de Tenet Healthcare Corporation (THC), a re莽u une attribution de 106 682 actions ordinaires qui ont 茅t茅 acquises sous forme d'actions restreintes li茅es 脿 la performance le 13/08/2025. Le dossier pr茅cise que l'attribution a 茅t茅 obtenue apr猫s que le comit茅 des ressources humaines ait certifi茅 la r茅alisation des objectifs de performance pour la p茅riode 1er janvier 2021 au 30 juin 2025. 脌 la suite de la transaction, Sutaria d茅tient 脿 titre b茅n茅ficiaire 475 365 actions. Le formulaire 4 a 茅t茅 sign茅 par un mandataire le 15/08/2025.

Saumya Sutaria, CEO und Direktorin von Tenet Healthcare Corporation (THC), erhielt eine Zuteilung von 106.682 Stammaktien, die am 13.08.2025 als leistungsgebundene Restricted Stock f盲llig wurden. Die Meldung gibt an, dass die Auszeichnung nach der Zertifizierung der Erreichung der Leistungsziele durch das Personal颅komitee f眉r den Zeitraum 1. Januar 2021 bis 30. Juni 2025 verdient wurde. Nach der Transaktion verf眉gt Sutaria wirtschaftlich 眉ber 475.365 Aktien. Das Formular 4 wurde am 15.08.2025 von einem Bevollm盲chtigten unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Sutaria Saumya
(Last) (First) (Middle)
14201 DALLAS PARKWAY
(Street)
DALLAS TX 75254
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
TENET HEALTHCARE CORP [ THC ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
CEO
3. Date of Earliest Transaction (Month/Day/Year)
08/13/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/13/2025 A(1) 106,682 A $0 475,365 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents a grant of performance-based restricted stock that was earned on the date the Human Resources Committee of the Company certified the achievement of the applicable performance targets based on the extent to which the applicable performance goals were attained for the performance period of January 1, 2021 to June 30, 2025.
Chad J. Wiener, as Attorney-in-fact for Saumya Sutaria 08/15/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

FAQ

What transaction did Tenet Healthcare (THC) report on the Form 4?

The Form 4 reports a grant that vested into 106,682 shares of common stock on 08/13/2025 for reporting person Saumya Sutaria.

Who is the reporting person on this Form 4 for THC?

The reporting person is Saumya Sutaria, who is identified as both a Director and the CEO of Tenet Healthcare Corporation.

How many shares does the reporting person own after the transaction?

Following the reported transaction, the filing shows beneficial ownership of 475,365 shares.

What performance period governed the awarded restricted stock?

The award was earned based on performance targets for the period January 1, 2021 to June 30, 2025, as certified by the Human Resources Committee.

Was there a cash price paid for the shares reported?

The Form 4 indicates a price of $0, consistent with restricted stock that vests rather than being purchased.
Stock THC logo
Tenet Healthcare Corp

NYSE:THC

THC Rankings

#690 Ranked by Market Cap
N/A Ranked by Dividends

THC Latest News

Aug 20, 2025
Tenet and USPI Named Foundational Sponsor of Inaugural AAOS Launchpad Program
Jul 22, 2025
Tenet Reports Strong Second Quarter 2025 Results; Raises 2025 Financial Outlook
Jun 23, 2025
Tenet to Report its Second Quarter 2025 Results on July 22nd
May 9, 2025
Tenet to Participate in BofA Securities 2025 Health Care Conference
Apr 29, 2025
Tenet Reports Strong First Quarter 2025 Results

THC Latest SEC Filings

Aug 20, 2025
[144] Tenet Healthcare Corporation New SEC Filing
Aug 15, 2025
[Form 4] Tenet Healthcare Corporation New Insider Trading Activity
Jul 22, 2025
[8-K] Tenet Healthcare Corporation New Reports Material Event

THC Stock Data

15.14B
87.21M
0.9%
100.2%
3.5%
Medical Care Facilities
Services-general Medical & Surgical Hospitals, Nec
United States
DALLAS